Skip to main content
SpringerLink
Log in

Anti-GD2 monoclonal antibody-associated ADRs

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Toxicity Spectrum of Anti-GD2 Immunotherapy: A Real-World Study Leveraging the US Food and Drug Administration Adverse Event Reporting System Pediatric Drugs : 28 Dec 2023. Available from: URL: https://doi.org/10.1007/s40272-023-00613-7

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Anti-GD2 monoclonal antibody-associated ADRs. Reactions Weekly 1992, 2 (2024). https://doi.org/10.1007/s40278-024-52735-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-024-52735-3

Search

Navigation